Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mastoidectomy Followed by Mastoid Obliteration Using S53P4 Bioactive Glass Versus Mastoidectomy Alone for Chronic Suppurative Otitis Media: a Retrospective Comparative Study

NCT06160505 is registered in ClinicalTrials.gov with Diakonessenhuis, Utrecht as lead sponsor.

NCT NCT06160505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06160505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mastoidectomy Followed by Mastoid Obliteration Using S53P4 Bioactive Glass Versus Mastoidectomy Alone for Chronic Suppurative Otitis Media: a Retrospective Comparative Study
Lead sponsor
Diakonessenhuis, Utrecht
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2023
Completion date
June 1, 2024
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic suppurative otitis media